1. Ahren T, Lithell H, Victor A, Vessby B, Johansson EDB (1981) Comparison of the metabolic effects ot two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apoliproteins. Contraceptions. Contraception 24: 451–468.
2. Archer TK, Tarn SP, Deeley RG (1986) Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells. J. Biol. Chem. 261: 5067–5074.
3. Castelli WP, Garrison RJ, Wilson P, Assert RD, Kaldusian S, Kamal WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. J. Am. Med. Ass. 256: 2835–2838.
4. Clarkson TB, Shively CA, Morgan TM, Koritnik DR, Adams MR, Kaplan JR (1990) Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet. Gynecol. 75: 217–222.
5. Farish E, Fletcher CD, Hart DM, Teo HT, Allazawi F, Howie C (1986) The effect of conjugated equine oestrogens with and without a cyclial progestogen on lipoproteins, and HDL subfractions in postmenopausal women. Acta Endocrinol. 113: 123–127.